Immunohistochemical prognosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and anti–synaptophysin.   The efficacy of two new monoclonal antibodies with cell lineage-restricted reactivity (HMB-45 [melanocytes]